SCHEMBL25983116

SCHEMBL25983116

Cc1ccccc1-c1ccc(C)c(-c2cc(-c3c(C)cccc3C)c(C)cn2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5AP P20292 1/20 0.49
▸ FEN1 P39748 1/20 0.49
▸ LCK P06239 1/20 0.47
▸ KDR P35968 1/20 0.47
▸ JAK3 P52333 1/20 0.47
▸ MAPK14 Q16539 1/20 0.47
▸ TRPA1 O75762 1/20 0.42
▸ CTSD P07339 1/20 0.42
▸ BACE1 P56817 1/20 0.42
▸ CYP2C19 P33261 7/20 0.41
▸ CYP1A2 P05177 6/20 0.41
▸ CYP2D6 P10635 6/20 0.41
▸ CLK4 Q9HAZ1 6/20 0.41
▸ HSD17B10 Q99714 2/20 0.41
▸ HTR7 P34969 2/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ PDK2 Q15119 1/20 0.40
▸ TSHR P16473 5/20 0.39
▸ CYP3A4 P08684 4/20 0.39
▸ ALDH1A1 P00352 4/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25983185 0.83 DHFR (0.39) ALOX5APFEN1LCKKDRJAK3
SCHEMBL24104302 0.79 LCK (0.42) ALOX5APFEN1LCKKDRJAK3
SCHEMBL22134614 0.79 LCK (0.39) ALOX5APFEN1LCKKDRJAK3
SCHEMBL25983007 0.76 ALOX5AP (0.44) ALOX5APFEN1LCKKDRJAK3
SCHEMBL25543839 0.74 CYP1A2 (0.47) ALOX5APFEN1LCKKDRJAK3
SCHEMBL24105023 0.74 PSMB5 (0.39) ALOX5APFEN1LCKKDRJAK3
SCHEMBL14654498 0.73 LDHA (0.44) ALOX5APFEN1KDRCYP2C19CYP1A2
SCHEMBL24105036 0.72 ALOX5AP (0.41) ALOX5APFEN1LCKKDRJAK3
SCHEMBL24066448 0.72 LDHA (0.46) ALOX5APFEN1KDRCYP2C19CYP1A2
SCHEMBL8115899 0.72 MCL1 (0.50) LCKKDRJAK3MAPK14TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2023-10-19 — — US disclosed
US-11725021-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2023-08-15 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11725021-B2 Organic electroluminescent materials and devices NCL, OCIAD2, OCIAD1 ALOX5AP 1270/4885FEN1 2848/4885LCK 1803/4885
US-20230331758-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES NCL, OCIAD2, OCIAD1 ALOX5AP 1270/4885FEN1 2848/4885LCK 1803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback